Search

everythinglearnresearchcommunity

for

Search:↓

Certain health conditions and hair care habits affect the treatment results for a scalp condition called Central Centrifugal Cicatricial Alopecia.

Alopecia Areata greatly affects the quality of life and mental health of Canadian patients and their caregivers.

The analysis aims to identify the most effective and safest treatments for alopecia areata.

Men have worse COVID-19 outcomes than women due to genetic and hormonal differences.

Treating alopecia areata is difficult due to limited approved treatments, but new therapies like JAK inhibitors show promise.

Apremilast may help treat lichen planopilaris and frontal fibrosing alopecia when other treatments fail.

Most drugs fail to reach the market, but understanding their properties and using strategies like early toxicity tests and drug repurposing can help advance their development.

Get head MRI for babies with achondroplasia early, use free immunoglobulin light chains to detect certain neurodevelopmental disorders, and video calls work for speech therapy in patients with facial anomalies.

Some drugs have gained approval for new uses, while others like tricyclic antidepressants and aspirin show promise but aren't yet approved for these uses.

Dermatologists should address erectile dysfunction in patients with skin conditions to improve their quality of life.

Pill splitting increased generic finasteride sales but didn't affect branded finasteride sales.

New treatments for children's scalp ringworm are recommended based on recent data.

Certain genes are linked to the risk of developing Alopecia Areata.

GLP-1RAs, like semaglutide and tirzepatide, may cause hair loss, so patients should be informed and monitored.

Baricitinib 4 mg should be used for at least 1 year to see significant hair regrowth in severe alopecia areata.

Experts agree on understanding hair aging to improve diagnosis and treatments.

COVID-19 and its vaccines can cause various skin issues due to viral effects, immune responses, and stress.

Deucravacitinib improves symptoms and reduces inflammation in Lichen Planopilaris.

New therapies for rare skin diseases show promise but need more research.

New treatments for hair loss show promise but need more testing for effectiveness and safety.

Dermatologists should respect Muslim patients' cultural and religious practices for better care.

All parts of the CLASI-A score are important for assessing skin activity in cutaneous lupus erythematosus.

More severe alopecia areata can lower quality of life.

Genetic factors, skin barrier, immune function, and obesity influence risk of fungal skin infections.

Pharmacy care clinics can reduce some emergency visits by managing certain conditions and medication issues.

Elderly skin care needs personalized treatment, early intervention, and integrated psychiatric care.

Minoxidil can treat hair loss with topical, oral, and sublingual options, offering personalized choices.

Poor sleep may lead to hair loss, and hair loss may affect sleep.

Rituximab treatment led to complete hair regrowth and improved skin in a woman with pemphigus foliaceus.